Publication Details
Publication: Health Industry Distribution Newspaper (健康産業流通新聞), No. 1160
Publication Date: May 14, 2026
Original Language: Japanese
English Translation of the Published Article
Note: The following English text is a faithful rendering of the information presented in the original Japanese media article. The content reflects the original media coverage.
Health Industry Distribution Newspaper reported on research into outdoor-cultivated Agaricus KA21 under the headline highlighting its potential usefulness for both men and women. The article introduces Toei Shinyaku’s continuing research on KA21 and several human and academic research themes.
It describes a study with Shigakkan University involving 24 men aged 50–70 years. Participants consumed 900 mg of Agaricus KA21 per day for two months, with evaluations including questionnaires related to aging symptoms and male sexual function.
The article also refers to other research involving KA21, including studies related to anti-beta-glucan antibodies and research themes in beauty and women’s health. It notes the company’s accumulation of patents and scientific evidence as part of its long-term research program.
The coverage presents Toei Shinyaku’s research strategy as extending across both men’s and women’s health while continuing to develop evidence for the outdoor-cultivated Agaricus KA21 ingredient.
日本語記事概要 / Japanese Summary
健康産業流通新聞2026年5月14日号で、「男女共に有用性示す」として露地栽培アガリクスKA21の研究が紹介されました。至学館大学との50～70歳男性24名を対象とした研究（900mg/日、2か月）をはじめ、抗β-グルカン抗体に関する研究、美容・女性の健康に関する研究テーマ、特許や学術的エビデンスの蓄積などが取り上げられています。